News, Articles and Updates
News
Stimulants tied to 46% of drug-related endocarditis hospitalizations: Study
Stimulants were involved in 46.2% of drug use-associated infective endocarditis hospitalizations in 2022, up from 37.3% in 2016, according to a study published Oct. 27 in Clinical Infectious Diseases. Researchers from the University of Colorado School of Medicine in Aurora, Washington University School of Medicine…
Oregon’s largest addiction center for moms to close after 37 years
Portland, Ore.-based Central City Concern will permanently close the Letty Owings Center, Oregon’s largest residential addiction treatment center for pregnant and parenting women, at the end of October, InvestigateWest reported Oct. 29. The 29-bed center opened in 1989 and allowed mothers to keep children up…
3 Behavioral Health Deals Defining 2026
This is an exclusive BHB+ article. 2026 hasn’t been a standout year for behavioral health deal volume, but it has produced some of the most interesting transactions in recent years. The digital health sector is finally starting to make headlines with major transactions. From Spring…
PsychPlus acquires Precision Psychiatric, adds 100+ psychiatrists
Houston-based PsychPlus has acquired Precision Psychiatric Services, a California psychiatric group, adding more than 100 psychiatrists to its clinical network. PsychPlus announced the deal Oct. 23. Financial terms were not disclosed. Precision, founded in 2018, is a physician-led organization with hospital partnerships across California. It…
Virginia mental health exec charged in $49M Medicaid fraud case
Mikia Antoneice Noble, co-owner and COO of Advancing Communities Everywhere, a mental health provider in the Richmond, Va., area, was arrested Oct. 28 on federal charges alleging the company billed Virginia Medicaid more than $49 million for crisis services it did not deliver as billed.…
A Case of Oral Budesonide–Induced Psychosis
Original Source: Journal of Clinical Psychiatry, all rights reserved. — Psychiatric side effects from systemic corticosteroids are relatively common, with severe reactions affecting approximately 6% of patients on agents such as prednisone and dexamethasone.1 Most cases involve mood disorders, with around one-sixth featuring psychosis or…
Depression in the Context of Medical Illness: Evaluation, Management, and the Risk of Suicide
Original Source: Journal of Clinical Psychiatry, all rights reserved. — Have you ever wondered whether depression that develops in the context of a medical illness is understandable and not pathological? Have you been unsure about whether (and when) you should initiate treatment (eg, pharmacologic or…
New York lands $10M to bring behavioral health into primary care
New York will receive $10 million in federal funding over five years to expand behavioral health services in primary care settings, New York Gov. Kathy Hochul announced Oct. 27. The state Office of Mental Health will administer the grant through a new initiative called Advancing…
Final Deadline for the 2026 Aspect Marketing & Advertising Awards Is October 31
The final deadline for the 2026 Aspect Marketing & Advertising Awards is Saturday, October 31, 2026 at 11:59pm CDT. The Aspect Marketing & Advertising Awards recognize outstanding creativity, innovation, and impact in marketing and advertising campaigns across the healthcare, post-acute care, and senior living sectors.…
Awareness of Alcohol Use Disorder Medication Is Low Among US Adults, Study Finds
National survey shows most US adults don’t know AUD medications exist, and safety concerns plus racial disparities shape hesitation toward treatment. — From Psychiatric Times articles Read More
Kaiser Permanente donates $15M to Oakland children’s hospital psychiatric unit
Oakland, Calif.-based Kaiser Permanente has given $15 million to UCSF Benioff Children’s Hospital Oakland to build a behavioral health wing that will include the hospital’s first dedicated inpatient psychiatric rooms. The 21,300-square-foot wing will have 20 private inpatient psychiatric rooms and is expected to serve…
White House walks back proposed kratom opioid ban despite safety concerns
Federal health officials have proposed loosening a ban on mitragynine pseudoindoxyl, or MGPI, a potent opioid compound found in some kratom products, to allow the substance at certain levels, The New York Times reported Oct. 28. HHS Secretary Robert F. Kennedy Jr. announced the policy…
Integrated Psychiatric Consultants
Office Hours:Mon-Fri, 9 a.m. - 5 p.m. CT